Enzymatic synthesis and mechanistic insights into the hepatoprotective effects of α-monoglucosyl rutin against cyclophosphamide-induced liver injury: a multi-omics approach
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115265 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Jing Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China. Hauptthemen laut MEDLINE: Rutin, Chemical and Drug Induced Liver Injury, Liver, Glucosyltransferases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Rutin has attracted widespread attention due to its multiple pharmacological activities, but inherent defects such as poor water solubility and low bioavailability have greatly limited its clinical applications. Therefore, this study employed cyclodextrin glucanotransferase (CGTase) to catalyze the glycosylation modification of rutin, preparing rutin derivatives with improved water solubility. After optimizing the conditions, we isolated and purified 98.33 % of high-purity α-monoglucosyl rutin (α-GR), and its structure was also characterized. Subsequently, the cyclophosphamide (CTX)-induced murine liver injury model was used for activity evaluation. Our results showed that α-GR could significantly reduce liver function indicators (AST, ALT, and TBA), regulate antioxidant enzyme activities and inflammatory factor levels, and effectively attenuate CTX-induced liver injury. Furthermore, integrated metabolomics, transcriptomics, and RT-PCR analyses indicated that α-GR primarily exerts its hepatoprotective effects by intervening in key metabolites and gene expressions in CTX metabolic processes, related inflammatory responses, and oxidative stress pathways. Our results show that α-GR can effectively repair liver damage caused by CTX, thus laying the foundation for its use as a dietary supplement or therapeutic adjuvant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
- Hangzhou Women's Hospital, Hangzhou 310008, China.
- ECA Healthcare Inc, Shanghai 201101, China.
- Medical Department, The Second Affiliated Hospital of Jiaxing University, Jiaxing 314000, China. Electronic address: jxeyluyun@126.com.
Zitieren
APA
Tian, J., Zhao, Y., Li, F., Xu, Y., Yi, W., Jiang, S., Tang, Y., & Lu, Y. (2025). Enzymatic synthesis and mechanistic insights into the hepatoprotective effects of α-monoglucosyl rutin against cyclophosphamide-induced liver injury: a multi-omics approach. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115265
Vancouver
Tian J, Zhao Y, Li F, Xu Y, Yi W, Jiang S, et al. Enzymatic synthesis and mechanistic insights into the hepatoprotective effects of α-monoglucosyl rutin against cyclophosphamide-induced liver injury: a multi-omics approach. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115265
BibTeX
@article{Tian2025,
author = {Tian, Jing and Zhao, Yanfeng and Li, Fanghang and Xu, Yezhu and Yi, Wenting and Jiang, Su and Tang, Yunping and Lu, Yun},
title = {Enzymatic synthesis and mechanistic insights into the hepatoprotective effects of α-monoglucosyl rutin against cyclophosphamide-induced liver injury: a multi-omics approach},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115265}
}
EUVIMED